OSE Immunotherapeutics SA's market cap is currently €151.15M. The company's EPS TTM is €2.088; its P/E ratio is 3.44; OSE Immunotherapeutics SA is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	€ 2.23M	€ 18.30M	€ 26.31M	€ 10.42M	€ 25.95M
Gross Profit	€ 2.23M	€ 18.30M	€ 26.31M	€ 10.42M	€ 25.94M
Operating Income	€ -22.99M	€ -24.04M	€ -21.97M	€ -24.74M	€ -5.06M
EBITDA	€ -17.50M	€ -15.68M	€ -14.65M	€ -18.72M	€ -1.24M
Net Income	€ -23.00M	€ -17.76M	€ -16.85M	€ -16.55M	€ -4.65M
Balance Sheet
Cash & Short-Term Investments	€ 18.67M	€ 25.62M	€ 33.58M	€ 29.37M	€ 25.84M
Total Assets	€ 82.05M	€ 91.67M	€ 101.52M	€ 96.85M	€ 88.89M
Total Debt	€ 45.80M	€ 44.79M	€ 37.13M	€ 19.51M	€ 11.48M
Net Debt	€ 27.13M	€ 19.17M	€ 3.55M	€ -9.85M	€ -14.36M
Total Liabilities	€ 59.08M	€ 59.12M	€ 53.99M	€ 35.61M	€ 30.40M
Stockholders' Equity	€ 22.82M	€ 32.55M	€ 47.53M	€ 61.24M	€ 58.49M
Cash Flow
Free Cash Flow	€ -20.00M	€ -18.53M	€ -10.39M	€ -19.76M	€ 8.63M
Operating Cash Flow	€ -19.76M	€ -18.25M	€ -9.92M	€ -19.55M	€ 8.97M
Investing Cash Flow	€ -507.00K	€ 26.00K	€ -827.00K	€ -504.00K	€ 2.38M
Financing Cash Flow	€ 13.32M	€ 10.27M	€ 14.96M	€ 23.58M	€ 4.92M

Currency in EUR

OSE Immunotherapeutics SA Earnings and Revenue History

Income Statement >

OSE Immunotherapeutics SA Debt to Assets

Balance Sheet >

OSE Immunotherapeutics SA Cash Flow

Cash Flow >

OSE Immunotherapeutics SA Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing